Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Arra

Showing results (101-110 of 143) with videos related to

Pageof 15
Sort By:
Endocrinology|September 10, 2005
A mouse model demonstrates a multigenic origin of congenital hypothyroidismElena Amendola, Pasquale De Luca, Paolo Emidio Macchia, et al.
Scientific Reports|May 4, 2017
Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic SarcomasMaria Vincenza Carriero, Katia Bifulco, Vincenzo Ingangi, et al.
International Journal of Cancer|July 28, 2007
The farnesyltransferase inhibitor R115777 (ZARNESTRA) enhances the pro-apoptotic activity of interferon-alpha through the inhibition of multiple survival pathwaysMichele Caraglia, Monica Marra, Caterina Viscomi, et al.
Infectious Agents and Cancer|July 31, 2015
Inhibitory effect of (-)-epigallocatechin-3-gallate and bleomycin on human pancreatic cancer MiaPaca-2 cell growthSabrina Bimonte, Maddalena Leongito, Antonio Barbieri, et al.
Oncotargets and Therapy|August 8, 2019
Dissecting the prevention of estrogen-dependent breast carcinogenesis through Nrf2-dependent and independent mechanismsAldo Giudice, Antonio Barbieri, Sabrina Bimonte, et al.
Oncogene|March 1, 2005
Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomasMonica Fedele, Francesca Pentimalli, Gustavo Baldassarre, et al.
Molecular Cancer Therapeutics|August 27, 2009
Structure-based design of an urokinase-type plasminogen activator receptor-derived peptide inhibiting cell migration and lung metastasisMaria Vincenza Carriero, Immacolata Longanesi-Cattani, Katia Bifulco, et al.
Journal of Medicinal Chemistry|February 2, 2011
Characterization of a designed vascular endothelial growth factor receptor antagonist helical peptide with antiangiogenic activity in vivoAnna Basile, Annarita Del Gatto, Donatella Diana, et al.
In Vivo (Athens, Greece)|April 24, 2016
Strain Analysis in the Assessment of a Mouse Model of Cardiotoxicity due to Chemotherapy: Sample for Preclinical ResearchDomenica Rea, Carmela Coppola, Antonio Barbieri, et al.
Cell Cycle (Georgetown, Tex.)|March 24, 2009
A point mutation (G574A) in the chemokine receptor CXCR4 detected in human cancer cells enhances migrationCaterina Ierano, Paola Giuliano, Crescenzo D'Alterio, et al.
Pageof 15

Showing results (101-110 of 143) with videos related to

Sort By:
Pageof 15
Endocrinology|September 10, 2005
A mouse model demonstrates a multigenic origin of congenital hypothyroidismElena Amendola, Pasquale De Luca, Paolo Emidio Macchia, et al.
Scientific Reports|May 4, 2017
Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic SarcomasMaria Vincenza Carriero, Katia Bifulco, Vincenzo Ingangi, et al.
International Journal of Cancer|July 28, 2007
The farnesyltransferase inhibitor R115777 (ZARNESTRA) enhances the pro-apoptotic activity of interferon-alpha through the inhibition of multiple survival pathwaysMichele Caraglia, Monica Marra, Caterina Viscomi, et al.
Infectious Agents and Cancer|July 31, 2015
Inhibitory effect of (-)-epigallocatechin-3-gallate and bleomycin on human pancreatic cancer MiaPaca-2 cell growthSabrina Bimonte, Maddalena Leongito, Antonio Barbieri, et al.
Oncotargets and Therapy|August 8, 2019
Dissecting the prevention of estrogen-dependent breast carcinogenesis through Nrf2-dependent and independent mechanismsAldo Giudice, Antonio Barbieri, Sabrina Bimonte, et al.
Oncogene|March 1, 2005
Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomasMonica Fedele, Francesca Pentimalli, Gustavo Baldassarre, et al.
Molecular Cancer Therapeutics|August 27, 2009
Structure-based design of an urokinase-type plasminogen activator receptor-derived peptide inhibiting cell migration and lung metastasisMaria Vincenza Carriero, Immacolata Longanesi-Cattani, Katia Bifulco, et al.
Journal of Medicinal Chemistry|February 2, 2011
Characterization of a designed vascular endothelial growth factor receptor antagonist helical peptide with antiangiogenic activity in vivoAnna Basile, Annarita Del Gatto, Donatella Diana, et al.
In Vivo (Athens, Greece)|April 24, 2016
Strain Analysis in the Assessment of a Mouse Model of Cardiotoxicity due to Chemotherapy: Sample for Preclinical ResearchDomenica Rea, Carmela Coppola, Antonio Barbieri, et al.
Cell Cycle (Georgetown, Tex.)|March 24, 2009
A point mutation (G574A) in the chemokine receptor CXCR4 detected in human cancer cells enhances migrationCaterina Ierano, Paola Giuliano, Crescenzo D'Alterio, et al.
Pageof 15